COVID might raise odds for immune disorders like Crohn's, alopecia
In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report.
Oct 10, 2023
0
58
In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report.
Oct 10, 2023
0
58
For patients with alopecia areata (AA), corticosteroids are the most commonly used treatment, and by one year, 71.8 percent are receiving no treatment, according to a study published online Sept. 20 in JAMA Dermatology.
Sep 20, 2023
0
1
A new type of medication, JAK inhibitors, can effectively treat moderate to severe alopecia areata, a hair loss condition that has been historically hard to treat.
Aug 17, 2023
0
9
Janus kinase (JAK) inhibitors are associated with more hair regrowth than placebo for patients with alopecia areata, according to a review published online June 27 in JAMA Network Open.
Jul 19, 2023
0
17
The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to Pfizer.
Jun 27, 2023
0
1
Alopecia areata (AA) is associated with a higher risk for inflammatory arthritis, according to a study published online April 28 in the Journal of the American Academy of Dermatology.
May 15, 2023
0
2
For patients with recalcitrant alopecia areata totalis or universalis, methotrexate combined with prednisone yields complete hair regrowth in about 31 percent of patients, according to a study published online March 8 in ...
Mar 15, 2023
0
5
The burden of alopecia areata (AA) is considerable in the United States, with people of color, especially Asians, disproportionately affected, according to a study published online March 1 in JAMA Dermatology.
Mar 6, 2023
0
8
Individuals with psoriasis have double the odds of having celiac disease (CD) versus individuals without psoriasis, according to a research letter published online Feb. 9 in the Journal of the American Academy of Dermatology.
Feb 28, 2023
0
14
The Food and Drug Administration on Monday approved a drug called baricitinib as the first oral tablet for treating severe alopecia areata, an autoimmune disorder affecting more than 300,000 people in the United States every ...
Jun 14, 2022
0
8